MENU
+Compare
MASI
Stock ticker: NASDAQ
AS OF
Jan 17 closing price
Price
$172.29
Change
+$2.35 (+1.38%)
Capitalization
7.66B

MASI Masimo Corp Forecast, Technical & Fundamental Analysis

a developer of medical signal processing technologies

MASI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for MASI with price predictions
Jan 08, 2025

Momentum Indicator for MASI turns positive, indicating new upward trend

MASI saw its Momentum Indicator move above the 0 level on January 08, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 89 similar instances where the indicator turned positive. In of the 89 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 50 cases where MASI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MASI advanced for three days, in of 332 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 265 cases where MASI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MASI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MASI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.615) is normal, around the industry mean (23.424). P/E Ratio (95.927) is within average values for comparable stocks, (83.627). Projected Growth (PEG Ratio) (4.833) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (3.826) is also within normal values, averaging (41.167).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MASI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
MASI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

MASI is expected to report earnings to rise 44.90% to $1.42 per share on March 04

Masimo Corp MASI Stock Earnings Reports
Q4'24
Est.
$1.42
Q3'24
Beat
by $0.14
Q2'24
Beat
by $0.09
Q1'24
Beat
by $0.07
Q4'23
Beat
by $0.37
The last earnings report on November 05 showed earnings per share of 98 cents, beating the estimate of 83 cents. With 616.44K shares outstanding, the current market capitalization sits at 7.66B.
A.I.Advisor
published Dividends

MASI paid dividends on December 11, 2012

Masimo Corp MASI Stock Dividends
А quarterly dividend of $1.00 per share was paid with a record date of December 11, 2012, and an ex-dividend date of November 23, 2012. Read more...
A.I. Advisor
published General Information

General Information

a developer of medical signal processing technologies

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
52 Discovery
Phone
+1 949 297-7000
Employees
5900
Web
https://www.masimo.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IQSM33.530.80
+2.43%
NYLI Candriam U.S. Mid Cap Equity ETF
PID18.480.08
+0.41%
Invesco International Div Achiev ETF
GEMD40.230.10
+0.24%
Goldman Sachs Access Emrg Mkts USD BdETF
FLOT51.00N/A
N/A
iShares Floating Rate Bond ETF
MFLX16.90N/A
N/A
First Trust Flexible Muncpl Hgh Inc ETF

MASI and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MASI has been loosely correlated with INSP. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if MASI jumps, then INSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MASI
1D Price
Change %
MASI100%
+1.38%
INSP - MASI
50%
Loosely correlated
+2.21%
TMCI - MASI
41%
Loosely correlated
+5.58%
NVRO - MASI
34%
Loosely correlated
+1.56%
EW - MASI
30%
Poorly correlated
-0.11%
HBIO - MASI
28%
Poorly correlated
+0.52%
More